Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: A systematic review and meta-analysis

Nephrology

Volumn 19, Issue 12, 2014, Pages 791-797

  Cheungpasitporn, Wisit ^a   Thongprayoon, Charat ^a   O'Corragain, Oisin A ^b   Edmonds, Peter J ^c   Kittanamongkolchai, Wonngarm ^a   Erickson, Stephen B ^a  

^a MAYO CLINIC   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

carbonated beverages; chronic kidney disease; soda; soft drink

Indexed keywords

CREATININE; SACCHARIN; SUGAR; SWEETENING AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; FOOD FREQUENCY QUESTIONNAIRE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR HYPERTENSION; RISK FACTOR; SOFT DRINK; STRUCTURED INTERVIEW; SYSTEMATIC REVIEW; VASOCONSTRICTION;

EID: 84964307789     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12343     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: General information and national estimates on chronic kidney disease in the United States, 2014. Atlanta, GA: Centers for Disease Control and Prevention, 2014.
2. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: Global dimension and perspectives. Lancet 2013; 382: 260-272.
3. Muntner P, Coresh J, Powe NR, Klag MJ,. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J. Am. Soc. Nephrol. 2003; 14: 1568-1577.
4. Chalmers L, Kaskel FJ, Bamgbola O,. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv. Chronic Kidney Dis. 2006; 13: 352-364.
5. Lastra G, Manrique C, Sowers JR,. Obesity, cardiometabolic syndrome, and chronic kidney disease: The weight of the evidence. Adv. Chronic Kidney Dis. 2006; 13: 365-373.
6. Kramer H, Luke A,. Obesity and kidney disease: A big dilemma. Curr. Opin. Nephrol. Hypertens. 2007; 16: 237-241.
7. Putnam JJ, Allshouse JE,. Food consumption, prices, and expenditures, 1970-97. Washington, DC: U.S. Department of Agriculture Economic Research Service, 1999.
8. Duffey KJ, Popkin BM,. High-fructose corn syrup: Is this what's for dinner? Am. J. Clin. Nutr. 2008; 88: 1722S-1732.
9. Gross LS, Li L, Ford ES, Liu S,. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the united states: An ecologic assessment. Am. J. Clin. Nutr. 2004; 79: 774-779.
10. Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007; 86: 899-906.
11. Ferder L, Ferder MD, Inserra F,. The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr. Hypertens. Rep. 2010; 12: 105-112.
12. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB,. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care 2010; 33: 2477-2483.
13. Ferraro PM, Taylor EN, Gambaro G, Curhan GC,. Soda and other beverages and the risk of kidney stones. Clin. J. Am. Soc. Nephrol. 2013; 8: 1389-1395.
14. Duffey KJ, Popkin BM,. Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity (Silver Spring) 2007; 15: 2739-2747.
15. Boden-Albala B, Sacco RL, Lee HS, et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 2008; 39: 30-35.
16. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Cardiol. Rev. 2005; 13: 322-327.
17. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385-390.
18. Saldana TM, Basso O, Darden R, Sandler DP,. Carbonated beverages and chronic kidney disease. Epidemiology 2007; 18: 501-506.
19. Shoham DA, Durazo-Arvizu R, Kramer H, et al. Sugary soda consumption and albuminuria: Results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS ONE 2008; 3: e3431.
20. Lin J, Curhan GC,. Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin. J. Am. Soc. Nephrol. 2011; 6: 160-166.
21. Bomback AS, Derebail VK, Shoham DA, et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int. 2010; 77: 609-616.
22. Bomback AS, Katz R, He K, Shoham DA, Burke GL, Klemmer PJ,. Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2009; 90: 1172-1178.
23. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010; 25: 603-605.
24. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
26. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR,. Publication bias in clinical research. Lancet 1991; 337: 867-872.
27. Karalius VP, Shoham DA,. Dietary sugar and artificial sweetener intake and chronic kidney disease: A review. Adv. Chronic Kidney Dis. 2013; 20: 157-164.
28. Gersch MS, Mu W, Cirillo P, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am. J. Physiol. Renal Physiol. 2007; 293: F1256-1261.
29. Sanchez-Lozada LG, Tapia E, Jimenez A, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal Physiol. 2007; 292: F423-429.
30. Berndt WO, Reddy RV, Hayes AW,. Evaluation of renal function in saccharin treated rats. Toxicology 1981; 21: 305-316.
31. Davidson TL, Swithers SE,. A Pavlovian approach to the problem of obesity. Int. J. Obes. Relat. Metab. Disord. 2004; 28: 933-935.
32. Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP,. Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring) 2008; 16: 1894-1900.
33. Freedman LS, Schatzkin A, Midthune D, Kipnis V,. Dealing with dietary measurement error in nutritional cohort studies. J. Natl Cancer Inst. 2011; 103: 1086-1092.
34. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927-934.